インスリン グラルギン
uk/44115/2/WRAP_Waugh_Newer_agents_blood.pdf.
↑ “Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis”. CMAJ 180 (4): 385–97. (February 2009). doi:10.1503/cmaj.081041. PMC 2638025. PMID 19221352. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638025/.
↑ “Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial”. Advances in Therapy 37 (5): 2413-2426. (April 2020). doi:10.1007/s12325-020-01332-y. PMC 7467476. PMID 32306247. https://link.springer.com/article/10.1007/s12325-020-01332-y.
↑ American Diabetes Association (2003). “Position statement: Insulin administration”. Diabetes Care 26 (Suppl.